GlaxoSmithKline Pharmaceuticals Limited (NSE:GLAXO)
India · Delayed Price · Currency is INR 2,440.70
-31.30 (-1.27%)
Apr 27, 2026, 3:30 PM IST
NSE:GLAXO Market Cap
NSE:GLAXO has a market cap or net worth of 414.21 billion as of April 27, 2026. Its market cap has decreased by -11.94% in one year.
Market Cap
414.21B
Enterprise Value
393.96B
Revenue
38.01B
Ranking
n/a
PE Ratio
40.57
Stock Price
2,440.70
Market Cap Chart
Since October 25, 2001, NSE:GLAXO's market cap has increased from 19.14B to 414.21B, an increase of 2,064.12%. That is a compound annual growth rate of 13.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2026 | 418.95B | 0.08% |
| Dec 31, 2025 | 418.59B | 9.72% |
| Dec 31, 2024 | 381.50B | 18.69% |
| Dec 29, 2023 | 321.43B | 43.86% |
| Dec 30, 2022 | 223.43B | -25.08% |
| Dec 31, 2021 | 298.24B | 8.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 3.89T |
| Divi's Laboratories | 1.69T |
| Apollo Hospitals Enterprise | 1.11T |
| Cipla | 1.05T |
| Biocon | 566.19B |
| Anthem Biosciences | 415.34B |
| Ipca Laboratories | 394.74B |
| Aster DM Healthcare | 364.48B |